Cynosure to Present at the Maxim Group Growth Conference

Tuesday, September 11, 2007 General News
Email Print This Page Comment
Font : A-A+

WESTFORD, Mass., Sept. 10 Cynosure, Inc.(Nasdaq: CYNO), a leading developer and manufacturer of a broad array oflight-based aesthetic treatment systems, today announced that the company willpresent at the First Annual Maxim Group Growth Conference in New York City.

Chief Financial Officer Timothy Baker will discuss Cynosure's businessoutlook, growth strategy and recent financial results in a presentationbeginning at 1:30 p.m. ET Thursday, September 20. The conference will be heldat the Grand Hyatt New York Hotel. Investors interested in listening to thelive webcast of this presentation should log on to the "Investor Relations"section of Cynosure's website, http://www.cynosure.com , and click on the linklabeled "Events." The presentation will be archived on the company's website.

The Maxim Group Growth Conference will feature interactive presentationsfrom over 70 companies, as well as one-on-one meetings with executives fromthe healthcare, technology, and special situations sectors. Attendees willinclude securities analysts, fund managers and institutional investors.

About Maxim Group

Maxim Group is a leading investment banking, securities and investmentmanagement firm. The Firm provides an array of financial services including:investment banking, equity research, private wealth management, structuredproducts, and global institutional equity, fixed-income and derivative sales &trading to a diverse range of corporate clients, institutional investors andhigh net worth individuals.

Maxim Group is registered as a broker-dealer with the U.S. Securities andExchange Commission and is a member of the following: National Association ofSecurities Dealers (NASD); Municipal Securities Rulemaking Board (MSRB);Securities Insurance Protection Corporation (SIPC); International SecuritiesExchange (ISE); NASDAQ Stock Market; and NYSE Arca, Inc. For additionalinformation, please visit http://www.maximgrp.com .

About Cynosure, Inc.

Cynosure, Inc. develops and markets aesthetic treatment systems that areused by physicians and other practitioners to perform non-invasive andminimally invasive procedures to remove hair, treat vascular lesions,rejuvenate skin through the treatment of shallow vascular and pigmentedlesions, laser lipolysis and temporarily reduce the appearance of cellulite.Cynosure's products include a broad range of laser and other light-basedenergy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, aswell as intense pulsed light. Cynosure was founded in 1991.

For corporate or product information, contact Cynosure at 800-886-2966, orvisit http://www.cynosure.com .Contact Scott Solomon Vice President Sharon Merrill Associates, Inc. 617-542-5300 cyno@investorrelations.com

SOURCE Cynosure, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook